Institutional investors purchased a net $2.6 million shares of CBLI during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 11.07% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 2.6 Million shares of Cleveland Biolabs Inc